Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Nature Communications
|
August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Harshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Future Oncology (London, England)
|
June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
JAMA
|
April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
Kimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Cancers
|
November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial
Justin C Brown, Michael H Rosenthal, Chao Ma, et al.
The New England Journal of Medicine
|
January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Cancer Discovery
|
July 8, 2026
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer
Andressa Dias Costa, Suryun Kim, Sung Chul Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017
Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2014
Hepatobiliary cancers, version 2.2014
Al B Benson, Michael I D'Angelica, Thomas A Abrams, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Nature Communications
|
August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Harshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Future Oncology (London, England)
|
June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
JAMA
|
April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
Kimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Cancers
|
November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial
Justin C Brown, Michael H Rosenthal, Chao Ma, et al.
The New England Journal of Medicine
|
January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Cancer Discovery
|
July 8, 2026
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer
Andressa Dias Costa, Suryun Kim, Sung Chul Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017
Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2014
Hepatobiliary cancers, version 2.2014
Al B Benson, Michael I D'Angelica, Thomas A Abrams, et al.
Page
of 5